drugset
Drugs / OrcaGraft
last change Apr 2026 re-read 3 minutes ago

OrcaGraft

also known as Orca-Q

Cell therapy

Developed for
acute lymphoblastic leukemia · mixed phenotype acute leukemia · myelodysplastic syndrome
Investigated by
Orca Biosystems, Inc.

Trials 1

today NCT03802695 · Ph 1
202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03802695 Apr 2019 → Dec 2027 expected acute lymphoblastic leukemia, mixed phenotype acute leukemia, myelodysplastic syndrome Orca Biosystems, Inc. Recruiting No outcome recorded

Press releases naming this drug 7 releases

DateIssuerRelease
2026-04-28 Orca Biosystems, Inc. Orca Bio Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Orca-Q® for the Treatment of High-Risk Hematologic Malignancies orcabio.com ↗
2025-02-12 Orca Biosystems, Inc. Orca Bio Presents Positive Phase 1 and 1b Data on Orca-T and Orca-Q at the 2025 Tandem Meetings of ASTCT® and CIBMTR® orcabio.com ↗
2024-12-07 Orca Biosystems, Inc. Orca Bio Presents Clinical Results on Use of Orca-Q without GvHD Prophylaxis in Patients with Hematological Malignancies at the 66th ASH Annual Meeting orcabio.com ↗
2023-12-09 Orca Biosystems, Inc. Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting orcabio.com ↗
2023-02-16 Orca Biosystems, Inc. Orca Bio Presents Positive Data Reinforcing Clinical Profile of Orca-T and Orca-Q at 2023 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR orcabio.com ↗
2022-12-12 Orca Biosystems, Inc. Orca Bio Presents Encouraging Interim Clinical Data on Orca-Q in Haploidentical Allogeneic Hematopoietic Stem Cell Transplants at 64th ASH Annual Meeting orcabio.com ↗
2022-11-03 Orca Biosystems, Inc. Orca Bio to Present Four Abstracts at the 64th American Society of Hematology Annual Meeting, Including Updated Relapse-Free Survival Data with Orca-T and the First Clinical Data for Orca-Q orcabio.com ↗

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as OrcaGraft ClinicalTrials.gov intervention name — accepted as the source's own label NCT03802695 ↗
Known as Orca-Q “OrcaGraft (Orca-Q)” NCT03802695 ↗
Modality Cell therapy “engineered donor grafts ("OrcaGraft"/"Orca-Q")” NCT03802695 ↗